Type 1 diabetes

Causes and mechanism

The condition is primarily an autoimmune process in which the immune system attacks the insulin-producing beta cells of the pancreatic islets. A combination of genetic susceptibility and environmental triggers (for example, certain infections or other factors) appears to initiate the autoimmune response. The resulting insulin deficiency distinguishes type 1 from conditions marked by insulin resistance.

Signs, diagnosis and distinctions

Typical symptoms include excessive thirst, frequent urination, unexplained weight loss, extreme hunger, fatigue and blurred vision. If untreated, rapid metabolic decompensation called diabetic ketoacidosis (DKA) may occur. Diagnosis is based on elevated blood glucose measurements and glycated hemoglobin (A1C); tests for islet autoantibodies can help confirm an autoimmune cause. Type 1 differs from type 2 diabetes in cause, typical age of onset and the need for immediate insulin therapy. A related form, latent autoimmune diabetes in adults (LADA), has features of both.

Management

Management centers on replacing insulin and preventing hypo- and hyperglycemia. Insulin can be delivered by multiple daily injections or by an insulin pump; strategies include basal–bolus regimens and continuous subcutaneous insulin infusion. Continuous glucose monitors (CGMs) and structured carbohydrate counting help people adjust doses. Education, regular follow-up, and attention to diet and activity are important complements to medical therapy.

Complications and importance

Long-term complications result from sustained high blood sugar and include microvascular damage such as retinopathy, nephropathy and peripheral neuropathy. People with type 1 are also at increased risk of macrovascular disease, including heart disease and stroke. Peripheral vascular problems and neuropathy increase the risk of foot ulcers and, in severe cases, gangrene. Acute complications include severe hypoglycemia and DKA.

History, prevalence and research

The introduction of insulin therapy in the early 1920s transformed type 1 diabetes from an acutely fatal illness to a chronic condition. Type 1 represents a minority of all diabetes cases worldwide (commonly reported in the single-digit to low-teens percentage range). Research priorities include automated insulin delivery systems, beta cell replacement (islet or whole-pancreas transplantation) and immune-based therapies aimed at preserving residual beta-cell function.

Practical points

• Type 1 requires lifelong insulin; oral glucose-lowering drugs used in type 2 are generally not sufficient.
• Regular screening for complications and self-monitoring of glucose are essential.
• Emergency plans for hypoglycemia and DKA should be in place for patients and caregivers.

For more clinical guidance and patient resources, consult specialist diabetes services and reliable health resources such as national diabetes organizations and professional guidelines (insulin therapy details and practical advice available through specialist sources).